申请人:Shiraishi Mitsuru
公开号:US20060178359A1
公开(公告)日:2006-08-10
A compound of the formula:
wherein R
1
is a 5- or 6-membered ring;
Z
1
is a 5- or 6-membered aromatic ring;
Z
2
is a group -Z
2a
-W
2
-Z
2b
-, wherein Z
2a
and Z
2b
are each O, S(O)
q
(wherein q is 0, 1 or 2), an imino group, or a bond; and W
2
is an alkylene chain;
W is a group represented by
wherein R
3
and R
3′
are each a hydrogen atom, a lower alkyl group, or a lower alkoxy group; X is CH or N; n and n′ are each an integer of 0 or 1 to 4; m and m′ are each 1 or 2; Y is O, S(O)
p
(wherein p is 0, 1 or 2), CH
2
or NR
4
(wherein R
4
is a hydrogen atom, a lower alkyl group, or a lower acyl group); and
R
2
is (1) an amino group, in which the nitrogen atom may be converted to a quaternary ammonium or an oxide, or (2) a nitrogen-containing heterocyclic group which may contain a sulfur atom or an oxygen atom as the ring-constituting atom, in which the nitrogen atom may be converted to a quaternary ammonium or an oxide; or a salt thereof. The compound exhibits excellent CCR antagonist activity against CCR5, and is useful as a prophylactic and/or therapeutic agent for HIV infection in human peripheral blood mononuclear cells, especially for AIDS.
一种化合物的化学式:其中R1是一个5-或6-成员环;Z1是一个5-或6-成员芳香环;Z2是一个-Z2a-W2-Z2b-基团,其中Z2a和Z2b分别是O、S(O)q(其中q为0、1或2)、亚胺基或键;W2是一个烷基链;W是一个由表示的基团,其中R3和R3'分别是氢原子、低烷基基团或低烷氧基基团;X是CH或N;n和n'分别是0或1至4的整数;m和m'分别是1或2;Y是O、S(O)p(其中p为0、1或2)、CH2或NR4(其中R4是氢原子、低烷基基团或低酰基基团);以及R2是(1)氨基,其中氮原子可以转化为季铵盐或氧化物,或(2)含氮杂环基团,该杂环基团可以包含硫原子或氧原子作为构成环的原子,其中氮原子可以转化为季铵盐或氧化物;或其盐。该化合物在CCR5上表现出优异的CCR拮抗活性,并且可用作人类外周血单个核细胞中HIV感染的预防和/或治疗剂,特别是用于艾滋病。